Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine. Mar 2007 - J Transl Med; 5:1479-5876 [PMID:17359532] [Adam C] [Mysliwietz J] [Mocikat R]
